| scholarly article | Q13442814 |
| P50 | author | Kuo-Chen Chou | Q30069869 |
| Dong-Qing Wei | Q78691557 | ||
| P2093 | author name string | Hong Guo | |
| Yu Zhu | |||
| Qi-Shi Du | |||
| Shu-Qing Wang | |||
| Suzanne Sirois | |||
| P2860 | cites work | Solution structure of BID, an intracellular amplifier of apoptotic signaling | Q27617719 |
| Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs | Q27641252 | ||
| The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor | Q27642450 | ||
| Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment | Q27764927 | ||
| Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
| A novel coronavirus associated with severe acute respiratory syndrome | Q29617553 | ||
| A model of the complex between cyclin-dependent kinase 5 and the activation domain of neuronal Cdk5 activator | Q33333805 | ||
| Subcellular location prediction of apoptosis proteins | Q34163319 | ||
| Kinetics of processive nucleic acid polymerases and nucleases | Q34293063 | ||
| Prediction of Protein Structural Classes | Q34297604 | ||
| Steady-state kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-87201E. | Q34305893 | ||
| Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204E. | Q34306379 | ||
| A vectorized sequence-coupling model for predicting HIV protease cleavage sites in proteins. | Q34352547 | ||
| Predicting cleavability of peptide sequences by HIV protease via correlation-angle approach | Q34357106 | ||
| Predicting human immunodeficiency virus protease cleavage sites in proteins by a discriminant function method | Q34379398 | ||
| Prediction of human immunodeficiency virus protease cleavage sites in proteins | Q34395418 | ||
| N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein | Q34554080 | ||
| Severe acute respiratory syndrome and influenza: virus incursions from southern China | Q35605213 | ||
| Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitor | Q38312049 | ||
| Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152E. | Q42275206 | ||
| The quinoline U-78036 is a potent inhibitor of HIV-1 reverse transcriptase. | Q42278148 | ||
| The benzylthio-pyrimidine U-31,355, a potent inhibitor of HIV-1 reverse transcriptase | Q42556920 | ||
| Prediction of the tertiary structure of the beta-secretase zymogen | Q43939436 | ||
| Identification of the N-terminal functional domains of Cdk5 by molecular truncation and computer modeling | Q44060634 | ||
| Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points | Q44904083 | ||
| A formulation for correlating properties of peptides and its application to predicting human immunodeficiency virus protease-cleavable sites in proteins | Q45774564 | ||
| Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. | Q51661127 | ||
| An alternate-subsite-coupled model for predicting HIV protease cleavage sites in proteins. | Q52384852 | ||
| Prediction of the tertiary structure of a caspase-9/inhibitor complex | Q73616626 | ||
| Prediction of the tertiary structure and substrate binding site of caspase-8 | Q74028194 | ||
| P433 | issue | 11 | |
| P921 | main subject | SARSr-CoV | Q278567 |
| SARS-CoV-1 | Q85438966 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 1857-1864 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide | |
| P478 | volume | 25 |
| Q44727152 | A novel fingerprint map for detecting SARS-CoV. |
| Q38028553 | Advances in visual representation of molecular potentials |
| Q53501563 | Cleavage mechanism of the H5N1 hemagglutinin by trypsin and furin. |
| Q45764150 | Computational studies of the binding modes of A 2A adenosine receptor antagonists |
| Q51907535 | Estimating residue evolutionary conservation by introducing von Neumann entropy and a novel gap-treating approach. |
| Q45421991 | From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus |
| Q46580414 | Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic alpha,beta-unsaturated esters |
| Q100514026 | Molecular mechanisms of the novel coronavirus SARS-CoV-2 and potential anti-COVID19 pharmacological targets since the outbreak of the pandemic |
| Q34390896 | Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase |
| Q43486256 | Peptide reagent design based on physical and chemical properties of amino acid residues |
| Q34461791 | Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase |
| Q42858751 | Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors |
Search more.